Outlook Therapeutics, Inc. - Common Stock (OTLK)

Last Price0.7590

Change+0.1735 (29.63%)

NASDAQ· Last Trade: May 28th, 12:48 PM EDT

Detailed Quote

Previous Close	0.5855
Open	0.6490
Bid	0.7580
Ask	0.7600
Day's Range	0.6103 - 0.7932
52 Week Range	0.1611 - 3.390
Volume	72,546,380
Market Cap	40.90M
PE Ratio (TTM)	-0.2897
EPS (TTM)	-2.6
Dividend & Yield	N/A (N/A)
1 Month Average Volume	24,247,635

About Outlook Therapeutics, Inc. - Common Stock (OTLK)

Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for eye diseases. The company specializes in the research and advancement of therapies aimed at addressing significant unmet medical needs in ophthalmology. Through its proprietary drug pipeline, Outlook Therapeutics is committed to enhancing the quality of life for patients affected by various retinal conditions, striving to bring new possibilities and improved outcomes to vision care. Read More

Outlook Therapeutics, Inc. - Common Stock (OTLK)

Detailed Quote

Chart

About Outlook Therapeutics, Inc. - Common Stock (OTLK)

News & Press Releases